2021
DOI: 10.1016/j.nano.2021.102371
|View full text |Cite
|
Sign up to set email alerts
|

The prospects of nanotherapeutic approaches for targeting tumor-associated macrophages in oral cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 180 publications
0
2
0
Order By: Relevance
“…Immunotherapy targeting TAMs has become a potential strategy for anti-tumor therapy based on the tumor-promoting mechanism of TAMs. Many treatments targeting TAMs have shown good results in preclinical studies ( Bhattacharya et al, 2021 ). Also, the combination of TAMs-targeting with traditional therapies has also achieved good results ( Dai et al, 2020b ).…”
Section: Immunotherapy Targeting Tumor-associated Macrophagesmentioning
confidence: 99%
“…Immunotherapy targeting TAMs has become a potential strategy for anti-tumor therapy based on the tumor-promoting mechanism of TAMs. Many treatments targeting TAMs have shown good results in preclinical studies ( Bhattacharya et al, 2021 ). Also, the combination of TAMs-targeting with traditional therapies has also achieved good results ( Dai et al, 2020b ).…”
Section: Immunotherapy Targeting Tumor-associated Macrophagesmentioning
confidence: 99%
“…Compared with their early counterparts, patients with OSCC in stage III/IV had a significantly poor prognosis and 5-year survival rates less than 30% due to recurrence and metastasis [4]. In addition, despite progress in the available treatments for advanced OSCC [5][6][7][8], the 5-year survival rate has not improved significantly during the past decades. Therefore, it is a major concern to explore the potential mechanism of recurrence and metastasis of OSCC.…”
Section: Introductionmentioning
confidence: 99%